Numerous cytokines involved in cell-mediated immunity, including IFN-γ, IL-6, MHC, and TNF-α molecules, have been associated with increased growth and patient prognosis in ovarian cancer (Nelson, 2008; Yanaihara et al., 2012). This evidence concerns the gene IL6 and ovarian carcinoma.